Ashwin N. Ananthakrishnan, MD, MPH
The American Gastroenterological Association recently released a guideline on the role of biomarkers in the management of Crohn’s disease (Gastroenterology 2023;165[6]:1367-1399). GEN’s Sarah Tilyou spoke with guideline lead author Ashwin N. Ananthakrishnan, MD, MPH, a gastroenterologist at Massachusetts General Hospital, in Boston, about the impetus for the guideline and what it means to GI practice.
GEN: What prompted the guideline?
Dr.